Author(s):
Mrityunjoy Majumdar, Nilendu Sekhar Sarkar, Debapriya Das, Arnab Samanta, Sourav Roy, Prodip Roy, Soumyadeb Dutta
Email(s):
prodiproy19951228@gmail.com
DOI:
10.52711/0974-360X.2024.00911
Address:
Mrityunjoy Majumdar1, Nilendu Sekhar Sarkar2, Debapriya Das1, Arnab Samanta3, Sourav Roy1, Prodip Roy1*, Soumyadeb Dutta1
1Department of Pharmacology, Netaji Subhas Chandra Bose Institute of Pharmacy, Chakdaha, Nadia, West Bengal, India – 741222.
2Indoriv Clinical Private Limited, 87, Chowringhee Road, Kolkata 700020, West Bengal, India.
3Department of Pharmaceutics, Netaji Subhas Chandra Bose Institute of Pharmacy, Chakdaha, Nadia, West Bengal, India – 741222.
*Corresponding Author
Published In:
Volume - 17,
Issue - 12,
Year - 2024
Cite this article:
Mrityunjoy Majumdar, Nilendu Sekhar Sarkar, Debapriya Das, Arnab Samanta, Sourav Roy, Prodip Roy, Soumyadeb Dutta. Preclinical evaluation of pods of Ageratina adenophora for its rudimentary fatal activity. Research Journal Pharmacy and Technology. 2024;17(12):6003-7. doi: 10.52711/0974-360X.2024.00911